These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18931703)

  • 1. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.
    Clark ES; Brown B; Whigham AS; Kochaishvili A; Yarbrough WG; Weaver AM
    Oncogene; 2009 Jan; 28(3):431-44. PubMed ID: 18931703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
    Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
    Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
    Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
    Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
    Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
    Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
    Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
    J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.
    Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR
    Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
    Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD
    Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update of knowledge on cortactin as a metastatic driver and potential therapeutic target in oral squamous cell carcinoma.
    Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Navarro-Triviño FJ; Gil-Montoya JA
    Oral Dis; 2019 May; 25(4):949-971. PubMed ID: 29878474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
    Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
    Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
    Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
    Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
    Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
    Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer.
    Kelley LC; Shahab S; Weed SA
    Clin Exp Metastasis; 2008; 25(4):289-304. PubMed ID: 18324357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
    Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
    PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma.
    Horn D; Gross M; Dyckhoff G; Fuchs J; Grabe N; Weichert W; Herpel E; Herold-Mende C; Lichter P; Hoffmann J; Hess J; Freier K
    Head Neck; 2018 Dec; 40(12):2685-2694. PubMed ID: 30456890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
    Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
    Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
    Dedes KJ; Lopez-Garcia MA; Geyer FC; Lambros MB; Savage K; Vatcheva R; Wilkerson P; Wetterskog D; Lacroix-Triki M; Natrajan R; Reis-Filho JS
    Breast Cancer Res Treat; 2010 Dec; 124(3):653-66. PubMed ID: 20213079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.